SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Current bottlenecks for improving accessibility and scalability of SARS-CoV-2 testing include diagnostic assay costs, complexity, and supply chain shortages. To resolve these issues, we developed SalivaDirect, which received Emergency Use...
Nathan Grubaugh
152d ago
1/6 We updated our SalivaDirect preprint with data from our @NBA cohort directly comparing saliva to swabs for asymptomatic #SARSCoV2 screening.
🏀 n=3,799 paired samples
🏀 0.3% invalid saliva rate
🏀 0.03-0.05% false positive rate
🏀 90% pos agreement
medrxiv.org/content/10.110… pic.twitter.com/ECvhMMyQdf
51
The updated #SalivaDirect preprint is now online, with a lot more 💦from @NBA players 🏀 tested by @aewatkins6 and @XtinaHarden!
